Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Profile of Innohep Versus Subcutaneous Unfractionated Heparin in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

NCT00277394 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00277394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Profile of Innohep Versus Subcutaneous Unfractionated Heparin in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
Lead sponsor
LEO Pharma
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
July 31, 2008
Enrollment
541 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis